Tengjun Biotechnology Corp.
Other OTCTotal Valuation
Tengjun Biotechnology Corp. carries a market capitalization of 201.42M, placing it among publicly traded companies globally.
| Market Cap | 201.42M |
| Enterprise Value | N/A |
Share Statistics
Tengjun Biotechnology Corp. currently has 100.71M shares outstanding.
| Shares Outstanding | 100.71M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Tengjun Biotechnology Corp. trades at a trailing price-to-earnings ratio of 483.72. The price-to-sales ratio is 33.40, and the price-to-book ratio stands at 421.38.
| PE Ratio | 483.72 |
| PS Ratio | 33.40 |
| PB Ratio | 421.38 |
| P/TBV Ratio | 225.51 |
| P/FCF Ratio | 159.09 |
| P/OCF Ratio | 158.39 |
Financial Position
Tengjun Biotechnology Corp. maintains a current ratio of 1.02, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.02 |
| Quick Ratio | 1.01 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 3.12 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 616.45 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.57 |
Taxes
Over the trailing twelve months, Tengjun Biotechnology Corp. has paid 2.90M in income taxes, reflecting an effective tax rate of 27.83.
| Income Tax | 2.90M |
| Effective Tax Rate | 27.83 |
Stock Price Statistics
Tengjun Biotechnology Corp.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 2.00, while the 200-day moving average is 2.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 2.00 |
| 200-Day Moving Average | 2.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tengjun Biotechnology Corp. generated 103.08M in revenue and converted that into 7.12M in net income, yielding earnings per share of 0.08. EBITDA reached 11.11M, while operating income came in at 11.26M.
| Revenue | 103.08M |
| Gross Profit | 96.63M |
| Operating Income | 11.26M |
| Pretax Income | 10.43M |
| Net Income | 7.12M |
| EBITDA | 11.11M |
| EBIT | 11.26M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
Total book value stands at 8.17M, with working capital of 6.80M providing operational flexibility.
| Cash & Cash Equivalents | 25.11M |
| Total Debt | N/A |
| Net Debt | -25.11M |
| Equity (Book Value) | 8.17M |
| Book Value Per Share | 0.09 |
| Working Capital | 6.80M |
Cash Flow
Tengjun Biotechnology Corp. produced 21.73M in operating cash flow over the past twelve months. After subtracting 95,264.00 in capital expenditures, free cash flow totaled 21.83M - equivalent to 0.23 per share.
| Operating Cash Flow | 21.73M |
| Capital Expenditures | 95,264.00 |
| Free Cash Flow | 21.83M |
| FCF Per Share | 0.23 |
Margins
Tengjun Biotechnology Corp. operates with a gross margin of 93.75, reflecting its pricing power and cost economics. The operating margin of 10.92 and net profit margin of 6.90 provide insight into operational efficiency.
| Gross Margin | 93.75 |
| Operating Margin | 10.92 |
| Pretax Margin | 10.12 |
| Profit Margin | 6.90 |
| EBITDA Margin | 10.78 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.03 |
| FCF Yield | 0.63 |
Scores
Tengjun Biotechnology Corp. posts an Altman Z-Score of 5.24, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.24 |